14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.95 $2.61 Wednesday, 24th Apr 2024 CHRS stock ended at $2.02. This is 7.34% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 9.41% from a day low at $2.02 to a day high of $2.21.
90 days $1.93 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Jul 10, 2023 $4.85 $5.30 $4.82 $5.20 3 789 442
Jul 07, 2023 $4.65 $4.92 $4.65 $4.85 2 553 797
Jul 06, 2023 $4.53 $4.73 $4.41 $4.64 2 827 954
Jul 05, 2023 $4.48 $4.72 $4.42 $4.57 8 205 003
Jul 03, 2023 $4.37 $4.59 $4.29 $4.42 2 389 026
Jun 30, 2023 $4.23 $4.34 $4.14 $4.27 2 045 222
Jun 29, 2023 $4.05 $4.21 $4.01 $4.19 2 065 812
Jun 28, 2023 $3.84 $4.11 $3.71 $4.05 2 810 080
Jun 27, 2023 $3.81 $3.93 $3.74 $3.84 2 168 106
Jun 26, 2023 $3.95 $3.96 $3.73 $3.81 2 312 366
Jun 23, 2023 $3.75 $4.00 $3.69 $3.99 4 315 922
Jun 22, 2023 $3.88 $3.92 $3.75 $3.79 3 205 737
Jun 21, 2023 $3.84 $3.96 $3.66 $3.87 7 000 820
Jun 20, 2023 $4.17 $4.19 $3.80 $3.84 6 604 698
Jun 16, 2023 $4.74 $4.76 $4.05 $4.13 20 222 872
Jun 15, 2023 $5.36 $5.45 $4.85 $5.39 6 751 558
Jun 14, 2023 $5.48 $5.48 $5.20 $5.36 1 923 201
Jun 13, 2023 $5.44 $5.55 $5.22 $5.44 2 141 182
Jun 12, 2023 $5.42 $5.63 $5.11 $5.38 2 733 632
Jun 09, 2023 $5.41 $5.60 $5.36 $5.42 2 382 646
Jun 08, 2023 $5.38 $5.49 $5.18 $5.39 1 960 719
Jun 07, 2023 $5.32 $5.63 $5.14 $5.38 4 018 101
Jun 06, 2023 $5.00 $5.48 $4.75 $5.27 4 927 142
Jun 05, 2023 $4.55 $5.02 $4.55 $4.98 4 548 039
Jun 02, 2023 $4.25 $4.51 $4.06 $4.45 4 409 196
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT